Company: NIVFW
Filing Date: 2025-08-21
Form Type: DRS
Source: 0001213900-25-079301
Chunk: 247

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-21
Form: DRS
Chunk 247
---

Stock Splits) and Series B Warrants to purchase an aggregate 180,722 Class A Ordinary Shares (without reflecting any Reverse Stock Splits).

Series A Warrants.

The
Series A Warrants expire nine years after the issuance date and are initially exercisable for an aggregate of 1,325,301 Class A Ordinary
Shares (the “Series A Warrant Shares”), subject to adjustment as provided therein. The initial exercise price of the Series
A Warrants is $0.913 per share, subject to adjustment as provided therein. If at the time of exercise of the Series A Warrants, there
is no effective registration statement registering the shares of our Ordinary Shares underlying such warrants, such warrants may be exercised
on a cashless basis pursuant to their terms.

Series B Warrants

The Series B Warrants expire
nine years after the issuance date and are initially exercisable for an aggregate of 180,722 Ordinary Shares, subject to adjustment as
provided therein. The Series B Warrants may be exercised at any time on or after February 12, 2025 (the “Initial Exercise Eligibility
Date”), subject to the Maximum Percentage. The initial exercise price of the Series B Warrants was prepaid, except for a nominal
exercise price of $0.001 per share, subject to adjustment as provided therein.

The form of the Series A Warrant
and form of the Series B Warrant are included as Exhibit B of the Securities Purchase Agreement included as Exhibit 4.1 in the Form 6-K
filed on August 16, 2024, which is incorporated herein by reference.

<div align='center'>II-2</div>

Second Tranche

On August 28, 2024, the Company
closed on the second tranche of the 2024 Debt Financing pursuant to the terms of the Securities Purchase Agreement. Under the second tranche,
the Company sold the First Mandatory Additional Note in the aggregate principal amount of $500,000. The First Mandatory Additional Note
is in substantially similar form to the Initial Note. Upon issuance of the First Mandatory Additional Note, the number of Class A Ordinary
Shares issuable upon exercise of the Series A Warrant automatically increased to 2,236,446 (equivalent to approximately 2,236 Class A
Ordinary Shares post Reverse Stock Splits). The First Mandatory Additional Note is included as Exhibit 4.1 in the Form 6-K filed on August
30, 2024, which is incorporated herein